FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

900000000000526001: referentieset voor associaties betreffende vervangende concepten (metadata)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
9093651000146111 referentieset voor associaties betreffende vervangende concepten nl Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Netherlands NRC maintained module (core metadata concept)
9093661000146114 referentieset voor associaties betreffende vervangende concepten (metadata) nl Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT Netherlands NRC maintained module (core metadata concept)


20431 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set (foundation metadata concept) Is a Historical association reference set (foundation metadata concept) true Inferred relationship Some

Members targetComponentId
Carbenoxolone sodium 2% oral gel Carbenoxolone 20 mg/g oromucosal gel
Carbidopa + levodopa 25mg/100mg m/r tablet Carbidopa 25 mg and levodopa 100 mg prolonged-release oral tablet
Carbidopa + levodopa 50mg/200mg m/r tablet Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug)
Carbidopa 10mg/levodopa 100mg orally disintegrating tablet Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug)
Carbidopa 18.75mg + levodopa 75mg + entacapone 200mg tablet Carbidopa anhydrous (as carbidopa) 18.75 mg and entacapone 200 mg and levodopa 75 mg oral tablet
Carbidopa 25mg Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram/1 each conventional release oral tablet (clinical drug)
Carbidopa 25mg/levodopa 100mg orally disintegrating tablet Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug)
Carbidopa 25mg/levodopa 250mg orally disintegrating tablet Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet
Carbidopa 31.25mg + levodopa 125mg + entacapone 200mg tablet Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet
Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 1mg/1mL/4mg/1mL/15mg/1mL drop Product containing precisely carbinoxamine maleate 1 milligram/1 milliliter and dextromethorphan hydrobromide 4 milligram/1 milliliter and pseudoephedrine hydrochloride 15 milligram/1 milliliter conventional release oral solution (clinical drug)
Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 4mg/5mL/12.5mg/5mL/60mg/5mL syrup Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 2.5 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug)
Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 4mg/5mL/15mg/5mL/60mg/5mL syrup Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug)
Carbinoxamine maleate+pseudoephedrine hydrochloride 1mg/1mL/15mg/1mL drops Carbinoxamine maleate 1 mg/mL and pseudoephedrine hydrochloride 15 mg/mL oral solution
Carbinoxamine maleate+pseudoephedrine hydrochloride 8mg/120mg m/r tablet Product containing only carbinoxamine and pseudoephedrine in oral dose form (medicinal product form)
Carbinoxamine maleate+pseudoephedrine hydrochloride 8mg/120mg prolonged-release oral tablet Product containing only carbinoxamine and pseudoephedrine in oral dose form (medicinal product form)
Carbohydrate agent Carbohydrate
Carbon-carbon lyase Carbon-carbon lyase
Carbon-halide lyase Carbon-halide lyase
Carbon-nitrogen lyase Carbon-nitrogen lyase
Carbon-oxygen lyase Carbon-oxygen lyase
Carbon-sulfur lyase Carbon-sulfur lyase (substance)
Carboplatin 600mg/60mL infusion Antineoplastic agent (substance)
Carboxy-lyase Decarboxylase
Carboxylic ester hydrolase Carboxylesterase
Carboxymethylcellulose sodium + hydroxyapatite injectable implant 1mL syringe Carmellose and hydroxyapatite only product in parenteral dose form
Carboxymethylcellulose sodium 16.58% oral paste Carmellose 166 mg/g oromucosal paste
Carbuncle of head, except face Carbuncle of head
Carbuncle of other specified site Carbuncle of skin and/or subcutaneous tissue (disorder)
Carcinoma in situ NOS Carcinoma in situ (disorder)
Carcinoma in situ NOS Carcinoma in situ (disorder)
Carcinoma in situ neoplastic process Carcinoma in situ (morphologic abnormality)
Carcinoma in situ of other and unspecified female genital organs Carcinoma in situ of female genital organ
Carcinoma in situ of other and unspecified female genital organs Carcinoma in situ of female genital organ
Carcinoma in situ of other and unspecified male genital organs Carcinoma in situ of male genital organ
Carcinoma in situ of other and unspecified male genital organs Carcinoma in situ of male genital organ
Carcinoma in situ of skin of other and unspecified parts of face Carcinoma in situ of skin of face
Carcinoma in situ of skin of other and unspecified parts of face Carcinoma in situ of skin of face
Carcinoma in situ of skin of other and unspecified parts of face NOS Carcinoma in situ of skin of face
Carcinoma in situ tumour Carcinoma in situ (disorder)
Carcinoma liver/biliary system NOS Carcinoma liver and/or biliary system (disorder)
Carcinoma of genital organs NOS Carcinoma of genital organ (disorder)
Carcinoma of genital organs NOS Carcinoma of genital organ (disorder)
Carcinoma of skin (excluding eyelid, vulva, penis, and melanomas) TNM finding American Joint Committee on Cancer allowable value
Carcinoma of skin of anterior portion of neck Carcinoma of skin of neck (disorder)
Cardiac arrest, unspecified Cardiac arrest (disorder)
Cardiac arrest, unspecified Cardiac arrest (disorder)
Cardiac dysrhythmia NOS Cardiac arrhythmia (disorder)
Cardiac dysrhythmia NOS Cardiac arrhythmia (disorder)
Cardiac end diastolic volume, function (observable entity) Cardiac end-diastolic volume (observable entity)
Cardiac status not worse than preoperative baseline Cardiac status is consistent with or improved from preoperative baseline (finding)
Cardio-oesophageal X-ray Plain X-ray of cardioesophageal junction with contrast
Cardiomyopathy NOS Cardiomyopathy
Cardiomyopathy NOS Cardiomyopathy
Cardiomyopathy due to drugs and other external agents Cardiomyopathy caused by drug
Cardioplegia perfusion solution Cardioplegic solution agent (substance)
Cardioplegia solution Cardioplegic solution agent (substance)
Cardituberculous cirrhosis Cirrhosis of liver (disorder)
Care of venous dissection Procedure on cardiovascular system
Care plan Care plan (record artifact)
Care plan Care plan (record artifact)
Care plan Care plan (record artifact)
Carglumic acid 200mg dispersible tablet Product containing precisely carglumic acid 200 milligram/1 each tablet for conventional release oral suspension (clinical drug)
Carglutamic acid 200mg dispersible tablet Product containing precisely carglumic acid 200 milligram/1 each tablet for conventional release oral suspension (clinical drug)
Carlavirus group Genus Carlavirus (organism)
Carmellose sodium 0.5% eye drops Product containing precisely carmellose sodium 5 milligram/1 milliliter conventional release eye drops (clinical drug)
Carmellose sodium 1% conventional release eye drops Product containing precisely carmellose sodium 10 milligram/1 milliliter conventional release eye drops (clinical drug)
Carmellose sodium 1% single-use eye drops Product containing precisely carmellose sodium 10 milligram/1 milliliter conventional release eye drops (clinical drug)
Carmustine 7.7mg wafer Product containing precisely carmustine 7.7 milligram/1 each prolonged-release intralesional implant (clinical drug)
Carnobacterium piscicola Carnobacterium maltaromaticum (organism)
Carotenosis cutis Carotene pigmentation of skin
Carpenter-Waziri-syndroom X-linked intellectual disability hypotonic face syndrome
Carvedilol 10mg controlled release capsule Product containing only carvedilol in oral dose form (medicinal product form)
Carvedilol 10mg prolonged-release oral capsule Product containing only carvedilol in oral dose form (medicinal product form)
Carvedilol 20mg controlled release capsule Product containing only carvedilol in oral dose form (medicinal product form)
Carvedilol 20mg prolonged-release oral capsule Product containing only carvedilol in oral dose form (medicinal product form)
Carvedilol 40mg controlled release capsule Product containing only carvedilol in oral dose form (medicinal product form)
Carvedilol 40mg prolonged-release oral capsule Product containing only carvedilol in oral dose form (medicinal product form)
Carvedilol 80mg controlled release capsule Product containing only carvedilol in oral dose form (medicinal product form)
Carvedilol 80mg prolonged-release oral capsule Product containing only carvedilol in oral dose form (medicinal product form)
Carya illinoensis Carya illinoinensis (organism)
Carya illinoensis diagnostic allergen extract Carya illinoinensis diagnostic allergen extract (product)
Carya illinoensis specific immunoglobulin E antibody measurement Carya illinoinensis specific immunoglobulin E antibody measurement (procedure)
Casmerodius albus Ardea alba (organism)
Casting or strapping procedure Stabilization
Casualty,not due to war, of accident NOS Accidental event (event)
Cat allergy vaccine Cat allergy vaccine (product)
Cat scratch disease Cat scratch disease
Cataract NOS Cataract
Cataract NOS Cataract
Catechin 15% topical ointment Catechin only product
Catheter ablation of right heart with myocardial biopsy Catheterization of right heart with myocardial biopsy (procedure)
Catheter patency solutions Pharmaceutical fluid or solution agent (substance)
Cation Electrolyte cation (substance)
Cauda equina injury without bone injury Cauda equina injury without spinal bone injury (disorder)
Cauda equina injury without bony injury Cauda equina injury without spinal bone injury (disorder)
Cauliflower Cauliflower (substance)
Cauliflower - dietary Cauliflower (substance)
Caustic injected into tumour Injection of caustic into neoplasm
Cauterisation NOS Cauterization
Cauterization NOS Cauterization
Cauterization of lesion of organ NOC Cauterization

Start Previous Page 22 of 205 Next End


Reference Sets

Reference set descriptor

Back to Start